These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7831243)

  • 1. [Fluoroquinolones in respiratory infections].
    Mouton Y; Leroy O
    Presse Med; 1994 Nov; 23(35):1616-20. PubMed ID: 7831243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections?
    Momméja-Marin H; Carbon C
    Drugs; 1999 Jun; 57(6):851-3. PubMed ID: 10400400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolones in respiratory infections.
    Klein NC
    Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fluoroquinolones in lower respiratory tract infections.
    Vellend H
    Clin Invest Med; 1989 Feb; 12(1):39-43. PubMed ID: 2920482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fluoroquinolones in respiratory tract infections.
    Grossman RF
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():59-62. PubMed ID: 9484874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluoroquinolones, 10 years later].
    de la Blanchardière A; Carbon C
    Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluoroquinolones: pharmacology, antibacterial spectrum and indications in pneumology].
    Underner M; Grignon B; Roblot F; Meurice JC; Patte F
    Rev Pneumol Clin; 1989; 45(1):14-22. PubMed ID: 2662344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 11. Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
    Stein GE; Havlichek DH
    Pharmacotherapy; 1997; 17(6):1139-47. PubMed ID: 9399598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zabofloxacin for chronic bronchitis.
    Kocsis B; Szabo D
    Drugs Today (Barc); 2016 Sep; 52(9):495-500. PubMed ID: 27883116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin, a second-generation fluoroquinolone.
    North DS; Fish DN; Redington JJ
    Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the fluoroquinolones.
    Guay DR
    Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolones in ambulatory ENT and respiratory tract infections: rarely appropriate.
    Prescrire Int; 2003 Feb; 12(63):26-7. PubMed ID: 12602405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of oral fluoroquinolones in patients with respiratory diseases].
    Ishida T
    Kekkaku; 2003 Oct; 78(10):653-9. PubMed ID: 14621574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission.
    Schaad UB; abdus Salam M; Aujard Y; Dagan R; Green SD; Peltola H; Rubio TT; Smith AL; Adam D
    Pediatr Infect Dis J; 1995 Jan; 14(1):1-9. PubMed ID: 7715981
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights on the appropriate use of fluoroquinolones in respiratory tract infections.
    Blasi F; Tarsia P; Aliberti S; Santus P; Allegra L
    Pulm Pharmacol Ther; 2006; 19 Suppl 1():11-9. PubMed ID: 16310389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animals.
    Klesel N; Geweniger KH; Koletzki P; Isert D; Limbert M; Markus A; Riess G; Schramm H; Seibert G; Iyer P
    Drugs; 1995; 49 Suppl 2():211-4. PubMed ID: 8549307
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
    Jones RN; Pfaller MA
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.